Palomino Laboratories (PALX) Free Cash Flow (2023 - 2025)
Palomino Laboratories (PALX) posted Free Cash Flow of -$343500.0 for Q3 2025, down 582.29% sequentially from -$50345.0 in Q2 2025, and down 1189.47% YoY from $31529.0 in Q3 2024.
Palomino Laboratories (PALX) Free Cash Flow (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported Free Cash Flow for 3 years, with the latest figure at -$343500.0 in Q3 2025.
- Quarterly Free Cash Flow fell 1189.47% year-over-year to -$343500.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$390793.0 (down 187.48% YoY) and the FY2024 annual result came in at -$166637.0, down 109.93% from the prior year.
- Free Cash Flow declined to -$343500.0 in Q3 2025 per PALX's latest filing, from -$50345.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $31529.0 in Q3 2024 and troughed at -$343500.0 in Q3 2025.
- A 3-year average of -$97249.5 and a median of -$53555.5 in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow plunged 195.01% in 2024, then slumped 1189.47% in 2025.
- Over 3 years, Free Cash Flow stood at -$56766.0 in 2023, then slumped by 195.01% to -$167467.0 in 2024, then slumped by 105.12% to -$343500.0 in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$343500.0, -$50345.0, and $3052.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -343,500.00 |
| Sep 30, 2025 | -343,500.00 |
| Jun 30, 2025 | -50,345.00 |
| Jun 30, 2025 | -50,345.00 |
| Mar 31, 2025 | 3,052.00 |
| Mar 31, 2025 | 3,052.00 |
| Dec 31, 2024 | -167,467.00 |
| Dec 31, 2024 | -167,467.00 |
| Sep 30, 2024 | 31,529.00 |
| Sep 30, 2024 | 31,529.00 |
| Dec 31, 2023 | -56,766.00 |
| Dec 31, 2023 | -56,766.00 |